Artificial intelligence was by far the hottest topic in both radiology and radiation oncology in 2019, and AI is the subject of 8 of the top 2019 ITN videos. This image is a prostate treatment plan created autonomously by a machine learning algorithm from RaySearch and is the subject of the No. 2 video on the list.
This is work-in-progress artificial intelligence app on Fujifilm's mobile digital radiography system to immediately detect pneumothorax (a collapsed lung), The AI highlights the area of interest to show the location to the technologist and attending physician in a unit before the image is even uploaded to the PACS for a read by a radiologist. The technology also can flag the study for an immediate read in the PACS worklist for confirmation by a human. This technology is from a third-party and will be offered on Fujifilm's REiLI AI platform. Applications like this that have immediate impact on critical patient care saw a lot of interest at RSNA 2019. Photos by ITN Editor Dave Fornell.
Introduced in 2018, the NeuroLogica OmniTom CT brings state-of-the-art 16-slice CT imaging to the patient bedside, operating room (OR) and other mobile clinical settings, raising the bar for mobile CT imaging. The new DORO clamp helps maximize the scanner’s performance for some of today’s most challenging interventions.
Ferrotran (formerly Combidex), based on Ferumoxtran-10, is the only contrast agent which can detect lymph node metastases as small as 2 mm diameter. Standard MRI or CT are not able to detect lymph node metastases smaller than 7 – 8 mm. Since most of the oncologic patients are dying due to metastases, a precise diagnostic is of utmost importance. The detection of small metastases, combined with the very clear and contrast rich MRI image of Ferrotran, enables an earlier and more precise treatment. Therefore, Ferrotran gives the patient a much higher chance of recovery.